Literature DB >> 487695

d-Propoxyphene kinetics after single oral and intravenous doses in man.

L F Gram, J Schou, W L Way, J Heltberg, N O Bodin.   

Abstract

d-Propoxyphene kinetics was studied in 8 healthy male subjects after single oral doses of d-propoxyphene at 65, 130, and 190 mg and after slow intravenous infusion of 65 mg. Total urinary excretion (7 days) indicated complete oral absorption but systemic availability was reduced corresponding to fist-pass elimination of 30% to 70%. There was linearity between oral dose and the corresponding area under the plasma concentration/time curve of d-propoxyphene and the metabolite norpropoxyphene. The kinetic measurements showed 2- to 3-fold interindividual variations: oral clearance, 1.3 to 3.6 1/min; systemic clearance, 0.6 to 1.2 1/min; apparent volume of distribution, 700 to 1,800 1; d-propoxyphene half-life (t1/2), 8 to 24 hr; and norpropoxyphene t1/2, 18 to 29 hr. There were pronounced intraindividual dose-dependent variations in oral clearance in some subjects. The intravenous concentration curves indicated a 3-compartment distribution model.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 487695     DOI: 10.1002/cpt1979264473

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  14 in total

Review 1.  Pharmacokinetics of opioids in liver disease.

Authors:  I Tegeder; J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

2.  Pharmacokinetics of dextropropoxyphene and nordextropropoxyphene in young and elderly volunteers after single and multiple dextropropoxyphene dosage.

Authors:  R J Flanagan; A Johnston; A S White; P Crome
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

Review 3.  Pharmacokinetics of opioids in renal dysfunction.

Authors:  G Davies; C Kingswood; M Street
Journal:  Clin Pharmacokinet       Date:  1996-12       Impact factor: 6.447

4.  Drug metabolite concentration-time profiles: influence of route of drug administration.

Authors:  J B Houston; G Taylor
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

5.  D-propoxyphene kinetics in man: significance of a deep third compartment.

Authors:  L F Gram; K Schmidt; F N Christensen; J Schou
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 6.  Dextropropoxyphene overdose. Epidemiology, clinical presentation and management.

Authors:  A A Lawson; D B Northridge
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Nov-Dec

7.  Dextropropoxyphene kinetics after single and repeated oral doses in man.

Authors:  K Brøsen; L F Gram; J Schou; N E Larsen; P Thayssen
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 8.  First-pass elimination. Basic concepts and clinical consequences.

Authors:  S M Pond; T N Tozer
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

9.  [Sustained-release dextropropoxyphene.].

Authors:  K Kurz-Müller; M Zenz
Journal:  Schmerz       Date:  1991-12       Impact factor: 1.107

10.  Pharmacokinetic interaction of propoxyphene with ethanol.

Authors:  E M Sellers; C A Hamilton; H L Kaplan; N C Degani; R L Foltz
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.